Skip to main content

Aharon Gil's Form 4 filing

Neuraxis, INC (NRXS) · filed Aug 17, 2026

Accession no.
0001493152-26-038815
Filed
Aug 17, 2026, 6:23 PM ET
Trade date
Jul 29-Aug 13, 2026
Filing delay
19 daysLate
Rule 10b5-1 plan
Not checked

This filing lists 3 non-derivative transactions. It was filed 19 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Aharon GilCIK 0001811824Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jul 29, 2026Common StockAGrant or awardAcquired+2,226–F1–36,128Direct
Aug 13, 2026Common StockAGrant or awardAcquired+43,930$6.28F2+$275,880.480,058Direct
Jul 29, 2026Common StockAGrant or awardAcquired+40,068–F1–548,123Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

The number of shares of common stock issued as a dividend on the Series B Preferred Stock to Rosalind Master Fund L.P. and the Reporting Person were 40,068 and 2,226, respectively, and was determined by dividing the accrued and unpaid 8.5% cumulative dividends on the respective Series B Preferred Stock (from the investment date, through the applicable record or conversion date) by $2.38.

Referenced by the price of 2 transactions in Table I.

F2

These shares of common stock were issued to the reporting person as compensation for services as independent director of the Issuer.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)